PROS1 and COVID-19: In this work, we presented the development of a label-free impedimetric capacitive immunosensor and demonstrated that the proof-of-concept device can selectively detect the total COVID-19-positive antibodies present in human serum samples; this is achieved by using the SARS-CoV-2 spike protein as the probe.